Variant report
Variant | nsv980496 |
---|---|
Chromosome Location | chr4:128378442-128391193 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:128385976..128387979-chr4:128391054..128393608,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MFSD8-3 | chr4:128378757-128378827 | ENSG00000248491 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000248491 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186206983 | chr4:128378781-128378782 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs75274564 | chr4:128378790-128378791 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs562435395 | chr4:128378802-128378803 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs563172697 | chr4:128384651-128384652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575385204 | chr4:128384673-128384674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34713973 | chr4:128384675-128384676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542403003 | chr4:128384682-128384683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77652374 | chr4:128384699-128384700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540479943 | chr4:128384740-128384741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528131235 | chr4:128384751-128384752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546633884 | chr4:128384780-128384781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564846928 | chr4:128384830-128384831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532882979 | chr4:128384847-128384848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs59141784 | chr4:128384867-128384868 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs574271061 | chr4:128384946-128384947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369567222 | chr4:128384963-128384964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569392502 | chr4:128384986-128384987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530313396 | chr4:128385030-128385031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183419622 | chr4:128385163-128385164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs60078422 | chr4:128385224-128385225 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs373252233 | chr4:128385249-128385250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187500672 | chr4:128385261-128385262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192633879 | chr4:128385262-128385263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201399579 | chr4:128385317-128385318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570492775 | chr4:128385335-128385336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531360518 | chr4:128385359-128385360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs137894344 | chr4:128385385-128385386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557217220 | chr4:128385416-128385417 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376431675 | chr4:128385420-128385421 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542813985 | chr4:128385437-128385438 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554432916 | chr4:128385445-128385446 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572996439 | chr4:128385489-128385490 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148409348 | chr4:128385503-128385504 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149474357 | chr4:128385507-128385508 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184523790 | chr4:128385508-128385509 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532136935 | chr4:128385510-128385511 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143954972 | chr4:128385523-128385524 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536022920 | chr4:128385524-128385525 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548781496 | chr4:128385530-128385531 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566926394 | chr4:128385573-128385574 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527810016 | chr4:128385574-128385575 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564839967 | chr4:128385593-128385594 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527336122 | chr4:128385605-128385606 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557607995 | chr4:128385646-128385647 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148926980 | chr4:128385663-128385664 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189844015 | chr4:128385676-128385677 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201368657 | chr4:128385685-128385686 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191700000 | chr4:128385724-128385725 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs77823982 | chr4:128385752-128385753 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs60045438 | chr4:128385799-128385800 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:128384600-128385400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr4:128384600-128385800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr4:128385000-128385400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr4:128385000-128385600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:128385000-128385600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr4:128385200-128385600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr4:128385400-128386000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |